Sweden· SE-20190805000085
Arupsan 200 mg Tablett
A medicinal product containing eslicarbazepine acetate, registered in Sweden by Accord Healthcare B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Eslicarbazepine Acetate
- Manufacturer
- Accord Healthcare B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190805000085
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eslicarbazepine acetate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAptiomSumitomo Pharma America, Inc.
- SpainARUPSAN 200 MG COMPRIMIDOS EFGAccord Healthcare S.L.U.
- United KingdomArupsan 200mg tabletsAccord-UK Ltd
- CzechiaZEBINIXBIAL - Portela & Ca., SA, S. Mamede do Coronado
- IcelandESLICARBAZEPIN DOCDOC Generici S.r.l.
- NetherlandsEslibon 200 mg tablettenG.L. Pharma GmbH
- PolandEslibonG.L. Pharma GmbH
- SwitzerlandZebinix 200 mg, comprimésBial SA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Eslibon
- Bulgaria · Еслибон
- Cyprus · Esran
- Czechia · Eslibon, Eslikarbazepin Neuraxpharm
- Germany · Eslibon, Eslicarbazepin Al
- Denmark · Arupsan, Eslicarbazepinacetat "stada"
- Spain · Arupsan, Bixcar
- France · Eslicarbazepine 800, Eslicarbazepine Arrow
- United Kingdom (Northern Ireland) · Arupsan, Eslicarbazepine Amarox
- Greece · Esran
- Hungary · Eslicarbazepine 800
- Iceland · Eslicarbazepin, Eslicarbazepine Acetate Stada
- Italy · Arupsan, Eslicarbazepina Acetato Aurobindo
- Liechtenstein · Zebinix
- Malta · Esran
- Netherlands · Eslibon
- Norway · Zebinix
- Poland · Eslibon
- Portugal · Acetato De Eslicarbazepina Alter, Acetato De Eslicarbazepina Aristo
- Slovakia · Eslibon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e4f8932-eedf-4aeb-8767-df964d1dbf96 GET /v1/drugs/8e4f8932-eedf-4aeb-8767-df964d1dbf96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"SmPC",
"sPAR",
"PL"
],
"se_npl_id": "20190805000085",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190805000085",
"product_doc_link": "https://docetp.mpa.se/LMF/Arupsan%20tablet%20SmPC_09001bee81c5b9ae.pdf"
}See everything about eslicarbazepine acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.